Abhijnan Chattopadhyay

Dr. Abhijnan Chattopadhyay

Internal Medicine - Division of Medical Genetics, The University of Texas Health Science Center at Houston, Houston, Texas, USA
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Open access
PDF file
Abhijnan ChattopadhyayAbhijnan Chattopadhyay
Abhijnan Chattopadhyay
CKCallie Kwartler
Callie Kwartler
KKKaveeta Kaw
Kaveeta Kaw
YLYanming Li
Yanming Li
AKAnita Kaw
Anita Kaw
DMDianna M. Milewicz
Dianna M. Milewicz
Objective: Vascular smooth muscle cells (SMCs) dedifferentiate and initiate expression of macrophage markers with cholesterol exposure. This phenotypic switching is dependent on the transcription factor Klf4 (Krüppel-like factor 4). We investigated the molecular pathway by which cholesterol induces SMC phenotypic switching. Approach and Results: With exposure to free cholesterol, SMCs decrease expression of contractile markers, activate Klf4, and upregulate a subset of macrophage and fibroblast markers characteristic of modulated SMCs that appear with atherosclerotic plaque formation. These phenotypic changes are associated with activation of all 3 pathways of the endoplasmic reticulum unfolded protein response (UPR), Perk (protein kinase RNA-like endoplasmic reticulum kinase), Ire (inositol-requiring enzyme) 1α, and Atf (activating transcription factor) 6. Blocking the movement of cholesterol from the plasma membrane to the endoplasmic reticulum prevents free cholesterol–induced UPR, Klf4 activation, and upregulation of the majority of macrophage and fibroblast markers. Cholesterol-induced phenotypic switching is also prevented by global UPR inhibition or specific inhibition of Perk signaling. Exposure to chemical UPR inducers, tunicamycin and thapsigargin, is sufficient to induce these same phenotypic transitions. Finally, analysis of published single-cell RNA sequencing data during atherosclerotic plaque formation in hyperlipidemic mice provides preliminary in vivo evidence of a role of UPR activation in modulated SMCs. Conclusions: Our data demonstrate that UPR is necessary and sufficient to drive phenotypic switching of SMCs to cells that resemble modulated SMCs found in atherosclerotic plaques. Preventing a UPR in hyperlipidemic mice diminishes atherosclerotic burden, and our data suggest that preventing SMC transition to dedifferentiated cells expressing macrophage and fibroblast markers contributes to this decreased plaque burden.

26 May 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
DPDecha Pinkaew
Decha Pinkaew
Abhijnan ChattopadhyayAbhijnan Chattopadhyay
Abhijnan Chattopadhyay
MKMatthew D. King
Matthew D. King
PCPreedakorn Chunhacha
Preedakorn Chunhacha
ZLZhihe Liu
Zhihe Liu
KFKen Fujise
Ken Fujise
The endoplasmic reticulum, the cytoplasmic organelle that matures a massive amount of nascent secretory polypeptides, is particularly sensitive to stress. Endoplasmic reticulum stress causes unfolded proteins to populate the organelle, eliciting the unfolded protein response. During the unfolded protein response, GRP78—an endoplasmic reticulum master stress regulator—detaches from three endoplasmic reticulum stress sensors (IRE1α, PERK, and ATF6) and allows them to activate the apoptotic signaling pathway. Fortilin, a pro-survival molecule, is known to inhibit apoptosis by binding and inhibiting p53, but its role in endoplasmic reticulum stress-induced apoptosis remains unknown. Here, we report that fortilin directly interacts with the cytoplasmic domain of IRE1α, inhibits both kinase and endoribonuclease (RNase) activities of the stress sensor, and protects cells against apoptotic cell death at both cellular and whole animal levels. Our data support a role of fortilin in the unfolded protein response and its potential participation in human diseases caused by unfolded protein response.

28 June 2023 in European Heart Journal
Verified
Journal Article
Open access
PDF file
KKKaveeta Kaw
Kaveeta Kaw
Abhijnan ChattopadhyayAbhijnan Chattopadhyay
Abhijnan Chattopadhyay
PGPujun Guan
Pujun Guan
JCJiyuan Chen
Jiyuan Chen
SMSuravi Majumder
Suravi Majumder
DMDianna M. Milewicz
Dianna M. Milewicz
The variant p.Arg149Cys in ACTA2, which encodes smooth muscle cell (SMC)-specific α-actin, predisposes to thoracic aortic disease and early onset coronary artery disease in individuals without cardiovascular risk factors. This study investigated how this variant drives increased atherosclerosis. Apoe−/− mice with and without the variant were fed a high-fat diet for 12 weeks, followed by evaluation of atherosclerotic plaque formation and single-cell transcriptomics analysis. SMCs explanted from Acta2R149C/+ and wildtype (WT) ascending aortas were used to investigate atherosclerosis-associated SMC phenotypic modulation. Hyperlipidemic Acta2R149C/+Apoe−/− mice have a 2.5-fold increase in atherosclerotic plaque burden compared to Apoe−/− mice with no differences in serum lipid levels. At the cellular level, misfolding of the R149C α-actin activates heat shock factor 1, which increases endogenous cholesterol biosynthesis and intracellular cholesterol levels through increased HMG-CoA reductase (HMG-CoAR) expression and activity. The increased cellular cholesterol in Acta2R149C/+ SMCs induces endoplasmic reticulum stress and activates PERK-ATF4-KLF4 signaling to drive atherosclerosis-associated phenotypic modulation in the absence of exogenous cholesterol, while WT cells require higher levels of exogenous cholesterol to drive phenotypic modulation. Treatment with the HMG-CoAR inhibitor pravastatin successfully reverses the increased atherosclerotic plaque burden in Acta2R149C/+Apoe−/− mice. These data establish a novel mechanism by which a pathogenic missense variant in a smooth muscle-specific contractile protein predisposes to atherosclerosis in individuals without hypercholesterolemia or other risk factors. The results emphasize the role of increased intracellular cholesterol levels in driving SMC phenotypic modulation and atherosclerotic plaque burden. Misfolding of Acta2 p.R149C activates heat shock factor 1 (HSF1), which in turn upregulates HMG-CoA reductase (HMG-CoAR) expression and activity, thereby increasing endogenous cholesterol biosynthesis. The increased levels of intracellular cholesterol induce endoplasmic reticulum (ER) stress, specifically activating the PERK-ATF4-KLF4 signaling axis, and lead to augmented smooth muscle cell (SMC) modulation in the absence of exogenous cholesterol in Acta2R149C/+ SMCs. CCT, chaperonin containing T-complex polypeptide-1; complex SMA, smooth muscle α-actin.

4 January 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
Abhijnan ChattopadhyayAbhijnan Chattopadhyay
Abhijnan Chattopadhyay
DPDecha Pinkaew
Decha Pinkaew
HDHung Q. Doan
Hung Q. Doan
RJReed B. Jacob
Reed B. Jacob
SVSunil K. Verma
Sunil K. Verma
KFKen Fujise
Ken Fujise
Fortilin, a pro-survival molecule, inhibits p53-induced apoptosis by binding to the sequence-specific DNA-binding domain of the tumor suppressor protein and preventing it from transcriptionally activating Bax. Intriguingly, fortilin protects cells against ROS-induced cell death, independent of p53. The signaling pathway through which fortilin protects cells against ROS-induced cell death, however, is unknown. Here we report that fortilin physically interacts with the antioxidant enzyme peroxiredoxin-1 (PRX1), protects it from proteasome-mediated degradation and keeps it enzymatically active by blocking its deactivating phosphorylation by Mst1, a serine/threonine kinase. At the whole animal level, the liver-specific overexpression of fortilin reduced PRX1 phosphorylation in the liver, enhanced PRX1 activity and protected the transgenic animals against alcohol-induced, ROS-mediated, liver damage. These data suggest the presence of a novel oxidative-stress-handling pathway where the anti-p53 molecule fortilin augments the peroxidase PRX1 by protecting it against degradation and inactivation of the enzyme. Fortilin-PRX1 interaction in the liver could be clinically exploited further to prevent acute alcohol-induced liver damage in humans.

16 June 2022 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Open access
PDF file
Abhijnan ChattopadhyayAbhijnan Chattopadhyay
Abhijnan Chattopadhyay
PGPujun Guan
Pujun Guan
SMSuravi Majumder
Suravi Majumder
KKKaveeta Kaw
Kaveeta Kaw
ZZZhen Zhou
Zhen Zhou
DMDianna M. Milewicz
Dianna M. Milewicz
Background: Vascular smooth muscle cells (SMCs) undergo complex phenotypic modulation with atherosclerotic plaque formation in hyperlipidemic mice, which is characterized by de-differentiation and heterogeneous increases in the expression of macrophage, fibroblast, osteogenic, and stem cell markers. An increase of cellular cholesterol in SMCs triggers similar phenotypic changes in vitro with exposure to free cholesterol due to cholesterol entering the endoplasmic reticulum, triggering endoplasmic reticulum stress and activating Perk (protein kinase RNA-like endoplasmic reticulum kinase) signaling. Methods: We generated an SMC-specific Perk knockout mouse model, induced hyperlipidemia in the mice by AAV- PCSK9 DY injection, and subjected them to a high-fat diet. We then assessed atherosclerotic plaque formation and performed single-cell transcriptomic studies using aortic tissue from these mice. Results: SMC-specific deletion of Perk reduces atherosclerotic plaque formation in male hyperlipidemic mice by 80%. Single-cell transcriptomic data identify 2 clusters of modulated SMCs in hyperlipidemic mice, one of which is absent when Perk is deleted in SMCs. The 2 modulated SMC clusters have significant overlap of transcriptional changes, but the Perk-dependent cluster uniquely shows a global decrease in the number of transcripts. SMC-specific Perk deletion also prevents migration of both contractile and modulated SMCs from the medial layer of the aorta. Conclusions: Our results indicate that hypercholesterolemia drives both Perk-dependent and Perk-independent SMC modulation and that deficiency of Perk significantly blocks atherosclerotic plaque formation.

21 June 2016 in Transcription
Verified
Journal Article
Open access
CKCatherine A. Kemme
Catherine A. Kemme
DNDan Nguyen
Dan Nguyen
Abhijnan ChattopadhyayAbhijnan Chattopadhyay
Abhijnan Chattopadhyay
JIJunji Iwahara
Junji Iwahara
Eukaryotic genomic DNA contains numerous high-affinity sites for transcription factors. Only a small fraction of these sites directly regulates target genes. Other high-affinity sites can serve as naturally present decoys that sequester transcription factors. Such natural decoys in genomic DNA may provide novel regulatory mechanisms for transcription factors.